MA26829A1 - Derives de purines - Google Patents

Derives de purines

Info

Publication number: MA26829A1
Authority: MA; Morocco
Prior art keywords: purine derivatives; purine; derivatives
Prior art date: 1999-10-14

Application number

MA26591A

Other languages

English (en)

Inventor

Marina Monaghan Sandra

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-14

Filing date

2002-04-09

Publication date

2004-12-20

2002-04-09 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26829A1 publication Critical patent/MA26829A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Emergency Medicine (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Psychiatry (AREA)

MA26591A 1999-10-14 2002-04-09 Derives de purines MA26829A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9924361.0A GB9924361D0 (en)	1999-10-14	1999-10-14	Purine derivatives

Publications (1)

Publication Number	Publication Date
MA26829A1 true MA26829A1 (fr)	2004-12-20

Family

ID=10862758

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26591A MA26829A1 (fr)	1999-10-14	2002-04-09	Derives de purines

Country Status (43)

Country	Link
US (1)	US6448236B1 (fr)
EP (1)	EP1220862B1 (fr)
JP (1)	JP3994008B2 (fr)
KR (1)	KR20030022758A (fr)
CN (1)	CN1166678C (fr)
AP (1)	AP2002002480A0 (fr)
AR (1)	AR026052A1 (fr)
AT (1)	ATE321065T1 (fr)
AU (1)	AU771531B2 (fr)
BG (1)	BG106567A (fr)
BR (1)	BR0014760A (fr)
CA (1)	CA2387533C (fr)
CO (1)	CO5261621A1 (fr)
CR (1)	CR6607A (fr)
CZ (1)	CZ20021179A3 (fr)
DE (1)	DE60026861T2 (fr)
EA (1)	EA004985B1 (fr)
EC (1)	ECSP003713A (fr)
EE (1)	EE200200194A (fr)
ES (1)	ES2257317T3 (fr)
GB (1)	GB9924361D0 (fr)
GE (1)	GEP20043324B (fr)
GT (2)	GT200000170A (fr)
HK (1)	HK1047942B (fr)
HR (1)	HRP20020325A2 (fr)
HU (1)	HUP0203485A3 (fr)
IL (1)	IL148331A0 (fr)
IS (1)	IS6287A (fr)
MA (1)	MA26829A1 (fr)
MX (1)	MXPA02003750A (fr)
MY (1)	MY141512A (fr)
NO (1)	NO20021751L (fr)
NZ (1)	NZ517294A (fr)
OA (1)	OA12060A (fr)
PA (1)	PA8503601A1 (fr)
PE (1)	PE20010753A1 (fr)
PL (1)	PL354880A1 (fr)
SK (1)	SK4742002A3 (fr)
SV (1)	SV2002000199A (fr)
TN (1)	TNSN00203A1 (fr)
TR (1)	TR200201001T2 (fr)
WO (1)	WO2001027131A1 (fr)
ZA (1)	ZA200202725B (fr)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0003960D0 (en)	2000-02-18	2000-04-12	Pfizer Ltd	Purine derivatives
GB0015727D0 (en) *	2000-06-27	2000-08-16	Pfizer Ltd	Purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
US20050033044A1 (en)	2003-05-19	2005-02-10	Bristol-Myers Squibb Pharma Company	Methods for preparing 2-alkynyladenosine derivatives
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
WO2005092893A1 (fr)	2004-03-26	2005-10-06	Dainippon Sumitomo Pharma Co., Ltd.	Compose 8-oxoadenine 9-substitue
TWI346109B (en) *	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
ATE462704T1 (de)	2004-05-26	2010-04-15	Inotek Pharmaceuticals Corp	Purinderivate als adenosin a 1 rezeptoragonisten und anwendungsverfahren dafür
RU2007114887A (ru) *	2004-09-20	2008-10-27	Инотек Фармасьютикалз Корпорейшн (Us)	Производные пурина и способы их применения
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
CA2625664C (fr)	2005-10-21	2016-01-05	Novartis Ag	Molecules organiques
JP5203214B2 (ja) *	2005-11-30	2013-06-05	イノテックファーマシューティカルズコーポレイション	プリン化合物およびその使用方法
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
PE20080361A1 (es) *	2006-04-21	2008-06-03	Novartis Ag	Compuestos derivados de purina como activadores del receptor de adenosina a2a
US8138172B2 (en)	2006-07-05	2012-03-20	Astrazeneca Ab	8-oxoadenine derivatives acting as modulators of TLR7
AU2007302263A1 (en)	2006-09-29	2008-04-03	Novartis Ag	Pyrazolopyrimidines as P13K lipid kinase inhibitors
WO2008052734A1 (fr)	2006-10-30	2008-05-08	Novartis Ag	Composés hétérocycliques en tant qu'agents anti-inflammatoires
TW200831105A (en) *	2006-12-14	2008-08-01	Astrazeneca Ab	Novel compounds
EP2118106A1 (fr) *	2007-03-02	2009-11-18	Glaxo Group Limited	Purines comme inhibiteurs de la cystéine protéase
EP2139894B1 (fr) *	2007-03-19	2011-10-26	AstraZeneca AB	Composés de 8 oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
EP2132209B8 (fr) *	2007-03-19	2014-04-16	AstraZeneca AB	Composés 8-oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
TW200902018A (en) *	2007-03-20	2009-01-16	Dainippon Sumitomo Pharma Co	Novel adenine compound
JPWO2008114819A1 (ja)	2007-03-20	2010-07-08	大日本住友製薬株式会社	新規アデニン化合物
PT2155743E (pt) *	2007-05-08	2012-10-30	Astrazeneca Ab	Imidazoquinolinas com propriedades imunomoduladoras
UY31531A1 (es)	2007-12-17	2009-08-03		Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
US8865896B2 (en)	2008-01-17	2014-10-21	Astrazeneca Aktiebolag	Method for preparing adenine compound
WO2009091031A1 (fr) *	2008-01-17	2009-07-23	Dainippon Sumitomo Pharma Co., Ltd.	Procédé de production d'un composé d'adénine
SI2391366T1 (sl)	2009-01-29	2013-01-31	Novartis Ag	Substituirani benzimidazoli za zdravljenje astrocitomov
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
KR20120089643A (ko)	2009-08-12	2012-08-13	노파르티스 아게	헤테로시클릭 히드라존 화합물, 및 암 및 염증을 치료하기 위한 그의 용도
US9085560B2 (en)	2009-08-17	2015-07-21	Intellikine, Inc.	Heterocyclic compounds and uses thereof
JP5775871B2 (ja)	2009-08-20	2015-09-09	ノバルティスアーゲー	ヘテロ環式オキシム化合物
JP2013512859A (ja) *	2009-12-03	2013-04-18	大日本住友製薬株式会社	トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン
EA025415B1 (ru)	2010-01-11	2016-12-30	Инотек Фармасьютикалз Корпорейшн	Комбинация, набор и способ снижения внутриглазного давления
WO2011119969A1 (fr)	2010-03-26	2011-09-29	Inotek Pharmaceuticals Corporation	Procédé de réduction de la pression intraoculaire chez l'homme à l'aide de n6-cyclopentyladénosine (cpa), de dérivés ou de promédicaments de cpa
WO2012034095A1 (fr)	2010-09-09	2012-03-15	Irm Llc	Composés et compositions comme inhibiteurs de trk
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
JP5978225B2 (ja)	2010-12-16	2016-08-24	大日本住友製薬株式会社	治療に有用なイミダゾ［４，５−ｃ］キノリン−１−イル誘導体
US8895570B2 (en)	2010-12-17	2014-11-25	Astrazeneca Ab	Purine derivatives
EP2673277A1 (fr)	2011-02-10	2013-12-18	Novartis AG	Composés de [1, 2, 4]triazolo [4, 3 -b]pyridazine en tant qu'inhibiteurs de la tyrosine kinase c-met
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
CA2828219A1 (fr)	2011-02-25	2012-08-30	Irm Llc	Composes et compositions en tant qu'inhibiteurs de trk
US9062045B2 (en)	2011-09-15	2015-06-23	Novartis Ag	Triazolopyridine compounds
US20130209543A1 (en)	2011-11-23	2013-08-15	Intellikine Llc	Enhanced treatment regimens using mtor inhibitors
HRP20171204T1 (hr)	2012-01-26	2017-10-06	Inotek Pharmaceuticals Corporation	Anhidridni polimorfi od [(2r,3s,4r,5r)-5-(6-(ciklopentilamino)-9h-purin- 9-il)-3,4-dihidroksitetrahidrofuran-2-il)]metil-nitrata i postupci njihove proizvodnje
ES2894830T3 (es)	2012-04-03	2022-02-16	Novartis Ag	Productos combinados con inhibidores de tirosina·cinasa y su uso
EA201591433A1 (ru)	2013-03-15	2015-12-30	Инотек Фармасьютикалс Корпорейшн	Офтальмологические составы
WO2014151147A1 (fr)	2013-03-15	2014-09-25	Intellikine, Llc	Combinaison d'inhibiteurs de kinase et ses utilisations
WO2015084804A1 (fr)	2013-12-03	2015-06-11	Novartis Ag	Combinaison d'un inhibiteur de mdm2 et d'un inhibiteur de braf, et leur utilisation
WO2016011658A1 (fr)	2014-07-25	2016-01-28	Novartis Ag	Polythérapie
KR20170036037A (ko)	2014-07-31	2017-03-31	노파르티스 아게	조합 요법
CA3102279A1 (fr)	2018-06-01	2019-12-05	Cornell University	Polytherapie pour maladie ou trouble associe a pi3k
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5536419A (en) *	1978-09-08	1980-03-14	Yamasa Shoyu Co Ltd	2-substituted adenosine derivative and its preparation
WO1988003147A1 (fr) *	1986-10-31	1988-05-05	Warner-Lambert Company	Adenosines a substitution n6 selectionees ayant une activite de liaison a2 selective
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5877180A (en) *	1994-07-11	1999-03-02	University Of Virginia Patent Foundation	Method for treating inflammatory diseases with A2a adenosine receptor agonists
GB9414193D0 (en)	1994-07-14	1994-08-31	Glaxo Group Ltd	Compounds
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
BR9914526A (pt) *	1998-10-16	2001-07-03	Pfizer	Derivados de adenina
GB9913932D0 (en)	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives

1999
- 1999-10-14 GB GBGB9924361.0A patent/GB9924361D0/en not_active Ceased
2000
- 2000-09-26 PA PA20008503601A patent/PA8503601A1/es unknown
- 2000-10-06 EP EP00962773A patent/EP1220862B1/fr not_active Expired - Lifetime
- 2000-10-06 KR KR1020027004766A patent/KR20030022758A/ko not_active Abandoned
- 2000-10-06 WO PCT/IB2000/001446 patent/WO2001027131A1/fr not_active Ceased
- 2000-10-06 JP JP2001530349A patent/JP3994008B2/ja not_active Expired - Fee Related
- 2000-10-06 OA OA1200200103A patent/OA12060A/en unknown
- 2000-10-06 AU AU74412/00A patent/AU771531B2/en not_active Ceased
- 2000-10-06 IL IL14833100A patent/IL148331A0/xx unknown
- 2000-10-06 ES ES00962773T patent/ES2257317T3/es not_active Expired - Lifetime
- 2000-10-06 HU HU0203485A patent/HUP0203485A3/hu unknown
- 2000-10-06 TR TR2002/01001T patent/TR200201001T2/xx unknown
- 2000-10-06 NZ NZ517294A patent/NZ517294A/en unknown
- 2000-10-06 GE GE4727A patent/GEP20043324B/en unknown
- 2000-10-06 BR BR0014760-5A patent/BR0014760A/pt not_active IP Right Cessation
- 2000-10-06 AT AT00962773T patent/ATE321065T1/de not_active IP Right Cessation
- 2000-10-06 DE DE60026861T patent/DE60026861T2/de not_active Expired - Fee Related
- 2000-10-06 CA CA002387533A patent/CA2387533C/fr not_active Expired - Fee Related
- 2000-10-06 EA EA200200360A patent/EA004985B1/ru not_active IP Right Cessation
- 2000-10-06 SK SK474-2002A patent/SK4742002A3/sk unknown
- 2000-10-06 CZ CZ20021179A patent/CZ20021179A3/cs unknown
- 2000-10-06 PL PL00354880A patent/PL354880A1/xx not_active Application Discontinuation
- 2000-10-06 AP APAP/P/2002/002480A patent/AP2002002480A0/en unknown
- 2000-10-06 EE EEP200200194A patent/EE200200194A/xx unknown
- 2000-10-06 HK HK03100163.8A patent/HK1047942B/zh not_active IP Right Cessation
- 2000-10-06 CN CNB008141762A patent/CN1166678C/zh not_active Expired - Fee Related
- 2000-10-06 MX MXPA02003750A patent/MXPA02003750A/es active IP Right Grant
- 2000-10-06 HR HR20020325A patent/HRP20020325A2/xx not_active Application Discontinuation
- 2000-10-10 GT GT200000170A patent/GT200000170A/es unknown
- 2000-10-12 MY MYPI20004789A patent/MY141512A/en unknown
- 2000-10-12 EC EC2000003713A patent/ECSP003713A/es unknown
- 2000-10-12 CO CO00077983A patent/CO5261621A1/es not_active Application Discontinuation
- 2000-10-12 GT GT200000173A patent/GT200000173A/es unknown
- 2000-10-13 SV SV2000000199A patent/SV2002000199A/es unknown
- 2000-10-13 TN TNTNSN00203A patent/TNSN00203A1/fr unknown
- 2000-10-13 AR ARP000105422A patent/AR026052A1/es unknown
- 2000-10-13 PE PE2000001099A patent/PE20010753A1/es not_active Application Discontinuation
- 2000-10-16 US US09/688,497 patent/US6448236B1/en not_active Expired - Fee Related
2002
- 2002-02-26 IS IS6287A patent/IS6287A/is unknown
- 2002-03-11 CR CR6607A patent/CR6607A/es not_active Application Discontinuation
- 2002-04-02 BG BG106567A patent/BG106567A/xx unknown
- 2002-04-08 ZA ZA200202725A patent/ZA200202725B/en unknown
- 2002-04-09 MA MA26591A patent/MA26829A1/fr unknown
- 2002-04-12 NO NO20021751A patent/NO20021751L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TR200201001T2 (tr)	2002-09-23
GT200000170A (es)	2002-04-03
OA12060A (en)	2006-05-03
HUP0203485A3 (en)	2005-02-28
MXPA02003750A (es)	2003-10-14
ES2257317T3 (es)	2006-08-01
CN1378551A (zh)	2002-11-06
EA004985B1 (ru)	2004-10-28
CA2387533C (fr)	2007-03-13
GT200000173A (es)	2002-04-05
ATE321065T1 (de)	2006-04-15
JP2003511460A (ja)	2003-03-25
HK1047942B (zh)	2005-04-01
NO20021751L (no)	2002-06-13
SK4742002A3 (en)	2003-05-02
KR20030022758A (ko)	2003-03-17
TNSN00203A1 (fr)	2002-05-30
EA200200360A1 (ru)	2002-10-31
GB9924361D0 (en)	1999-12-15
JP3994008B2 (ja)	2007-10-17
NZ517294A (en)	2004-03-26
PE20010753A1 (es)	2001-07-17
BR0014760A (pt)	2002-07-02
SV2002000199A (es)	2002-02-05
EP1220862B1 (fr)	2006-03-22
BG106567A (en)	2002-12-29
AU7441200A (en)	2001-04-23
CA2387533A1 (fr)	2001-04-19
ZA200202725B (en)	2003-04-08
AU771531B2 (en)	2004-03-25
CN1166678C (zh)	2004-09-15
AR026052A1 (es)	2002-12-26
IS6287A (is)	2002-02-26
EE200200194A (et)	2003-06-16
MY141512A (en)	2010-05-14
PA8503601A1 (es)	2002-02-21
CO5261621A1 (es)	2003-03-31
HK1047942A1 (zh)	2003-03-14
GEP20043324B (en)	2004-04-13
NO20021751D0 (no)	2002-04-12
US6448236B1 (en)	2002-09-10
ECSP003713A (es)	2002-05-23
AP2002002480A0 (en)	2002-06-30
DE60026861T2 (de)	2006-09-21
CR6607A (es)	2003-11-25
EP1220862A1 (fr)	2002-07-10
DE60026861D1 (de)	2006-05-11
HUP0203485A2 (hu)	2003-03-28
WO2001027131A1 (fr)	2001-04-19
IL148331A0 (en)	2002-09-12
HRP20020325A2 (en)	2004-04-30
PL354880A1 (en)	2004-03-22
CZ20021179A3 (cs)	2003-04-16

Publication	Publication Date	Title
MA26829A1 (fr)	2004-12-20	Derives de purines
MA26828A1 (fr)	2004-12-20	Derives de purines
MA26799A1 (fr)	2004-12-20	Derives de purine
MA26918A1 (fr)	2004-12-20	Derives de purine
ATE231874T1 (de)	2003-02-15	Antivirale purin-derivate
DE60119492D1 (de)	2006-06-14	Purinderivate
NO20010743D0 (no)	2001-02-14	Antivirale indoloksoacetyl-piperazin-derivater
MA26967A1 (fr)	2004-12-20	Derives de pyrimidine
ES1050663Y (es)	2002-08-16	Batidor de purines perfeccionado